EDUCATION
- 2011Yonsei University, Department of Biotechnology, Republic of Korea Ph.D. in Medicinal chemistry
- 1996Korea University, Department of Biotechnology, Republic of Korea M.S. in Biochemistry
- 1994Korea University, Department of Biotechnology, Republic of Korea B.S. in Biotechnology
Major Research Achievements
- 2023–2024Yunovia Pharm. Managing Director, Head of Innovative Solution Group
- 2016–2023Ildong Pharma. Managing Director, Head of Innovative Solution Group
- 2012–2016CalIBR(California Institute for Biomedical Research, CA, US) Research Scientist
- 1996–2012Daewoong Pharma. Research fellow, Department of Drug discovery
Research Paper(last 3-years only)
- 2023Synthetic Strategies for Improving Solubility: Optimization of Novel Pyrazolo[1,5-a]pyrimidine CFTR Activator That Ameliorates Dry Eye Disease. Journal of Medicinal Chemistry (ACS publicatin
- 2023Discovery of ID110521156, a Small Molecule GLP-1 Receptor Agonist, for the Treatment of Type 2 Diabetes and Obesity. ADA 83th Scientific sessions poster (American Diabetes association)
- 2022Novel CFTR Activator Cact-3 Ameliorates Ocular Surface Dysfunctions in Scopolamine- Induced Dry Eye Mice. International Journals of Molecular Sciences (MDPI)
- 2021Discovery of 5-(N-hydroxy carbamimidoyl) benzofuran derivatives as novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. Bioorganic & Medicinal Chemistry Letters (Elsevier)
Patents(last 3-years PCT only)
- WO 2024/085661A1Novel triheterocyclic compounds
- WO 2024/063576A1Novel quinazoline compound as KRAS inhibitor
- WO 2024/063578A1Novel tetraheterocycle compound
- WO 2024/019541A1Heteroaryl derivative compound and use thereof
- WO 2024/014885A1Novel Bicyclic heteroaryl compound and use thereof
- WO 2023/182869A1Novel salt of GLP-1receptor agonist compound, preparation method thereof and pharmaceutical composition thereof
- WO 2023/113474A1Novel salt of1-sulfonyl pyrrole derivative, Method for preparing same, and Pharmaceutical composition including same
- WO 2023/113458A1Novel salt of1-sulfonyl pyrrole derivative, preparation method thereof and pharmaceutical comprising thereof
- WO 2023/067388A1Uses of CFTR modulatorand/or PDE4 inhibitor compounds
- WO 2022/231357A1Pharmaceutical comprising GPR40 agonist and SGLT-2 inhibitor
- WO 2022/195522A1Inhibitors of ANO6 and their uses thereof
- WO 2022/157686A1Inhibitors of Anoctamin6 protein and their uses thereof
- WO 2022/123319A1Biased agonists of opioid receptors
- WO 2022/084741A1CFTR modulator compounds, compositions, and uses thereof